12:00 AM
Sep 10, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Trevena preclinical data

In a canine model of heart failure, furosemide plus TRV027 led to significant reductions in mean arterial pressure, systemic and pulmonary vascular resistances, pulmonary capillary wedge pressure and

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >